BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35537410)

  • 21. CD103
    Jin K; Yu Y; Zeng H; Liu Z; You R; Zhang H; Liu C; Su X; Yan S; Chang Y; Xu L; Xu J; Zhu Y; Wang Z
    Br J Cancer; 2022 Jun; 126(11):1581-1588. PubMed ID: 35165401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUDT1 promotes the accumulation and longevity of CD103
    Huang B; Lyu Z; Qian Q; Chen Y; Zhang J; Li B; Li Y; Liang J; Liu Q; Li Y; Chen R; Lian M; Xiao X; Miao Q; Wang Q; Fang J; Lian Z; Li Y; Tang R; Helleday T; Gershwin ME; You Z; Ma X
    J Hepatol; 2022 Nov; 77(5):1311-1324. PubMed ID: 35753523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival.
    Vlaming M; Bilemjian V; Freile JÁ; Melo V; Plat A; Huls G; Nijman HW; de Bruyn M; Bremer E
    Front Immunol; 2022; 13():1031746. PubMed ID: 36341460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
    Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of CD69
    Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
    Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct recirculation potential of CD69
    Park SL; Mackay LK; Gebhardt T
    Immunol Cell Biol; 2016 Nov; 94(10):975-980. PubMed ID: 27328704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8
    Gauthier L; Corgnac S; Boutet M; Gros G; Validire P; Bismuth G; Mami-Chouaib F
    Cancer Res; 2017 Dec; 77(24):7072-7082. PubMed ID: 29021139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD103 fate mapping reveals that intestinal CD103
    Fung HY; Teryek M; Lemenze AD; Bergsbaken T
    Sci Immunol; 2022 Nov; 7(77):eabl9925. PubMed ID: 36332012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-Resident Memory CD8
    Topham DJ; Reilly EC
    Front Immunol; 2018; 9():515. PubMed ID: 29632527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
    PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity.
    Chen Y; Yan SM; Pu Z; Feng J; Tan L; Li Y; Hu H; Huang W; Lin Y; Peng Z; He X; Huang F; Zhang H; Zhang Y
    Cancer Res; 2022 Sep; 82(17):3130-3142. PubMed ID: 35802647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICOS-play: dressing T cells for residency.
    Park SL; Christo SN; Mackay LK
    Trends Immunol; 2022 Apr; 43(4):280-282. PubMed ID: 35272933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation.
    Qiu Z; Khairallah C; Chu TH; Imperato JN; Lei X; Romanov G; Atakilit A; Puddington L; Sheridan BS
    J Exp Med; 2023 May; 220(5):. PubMed ID: 36809399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity.
    Molodtsov A; Turk MJ
    Front Immunol; 2018; 9():2810. PubMed ID: 30555481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-Resident Memory-like Lymphocytes Demonstrate Effector Activity in Ovarian Cancer.
    Cancer Discov; 2022 Jun; 12(6):OF11. PubMed ID: 35452079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-Resident Memory CD8
    Enamorado M; Khouili SC; Iborra S; Sancho D
    Front Immunol; 2018; 9():1751. PubMed ID: 30108585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local Inflammatory Cues Regulate Differentiation and Persistence of CD8
    Bergsbaken T; Bevan MJ; Fink PJ
    Cell Rep; 2017 Apr; 19(1):114-124. PubMed ID: 28380351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancers.
    Talhouni S; Fadhil W; Mongan NP; Field L; Hunter K; Makhsous S; Maciel-Guerra A; Kaur N; Nestarenkaite A; Laurinavicius A; Willcox BE; Dottorini T; Spendlove I; Jackson AM; Ilyas M; Ramage JM
    Front Immunol; 2023; 14():1057292. PubMed ID: 37251410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
    Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
    Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty Acid Oxidation Controls CD8
    Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
    Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.